Inducible T cell co-stimulatory (ICOS) receptor agonist, GSK3359609 (GSK609) alone and combination with pembrolizumab: Preliminary results from INDUCE-1 expansion cohorts in head and neck squamous cell carcinoma (HNSCC)

C. Le Tourneau,D. Rischin, S. Groenland,A. Lim,J. Martin-Liberal,V. Moreno,J. M. Trigo, M. Mathew,D. Cho,A. Hansen, D. Vincente Baz, M. Maio, A. Italiano,J. Bauman, M. Chisamore,H. Zhou,C. Ellis, M. Ballas,A. Hoos,E. Angevin

Annals of Oncology(2020)

引用 4|浏览54
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要